TMDX — TransMedics Group, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1756262 ·
Last close
$85.29
Market Cap
$2.96B
52W High
$156.00
52W Low
$60.10
ADV30
698,383
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 189,948,000 | 113,198,000 | 23,736,000 | 14,682,000 | 1,464,396,000 | 472,675,000 | 946,343,000 |
| Mar 2026 | 173,933,000 | 101,161,000 | 13,297,000 | 7,315,000 | 1,434,820,000 | 461,739,000 | 940,813,000 |
| Dec 2025 | 160,764,000 | 93,414,000 | 21,273,000 | 105,383,000 | 1,068,373,000 | 488,366,000 | 595,273,000 |
| Sep 2025 | 143,823,000 | 84,575,000 | 23,300,000 | 24,319,000 | 946,032,000 | 466,174,000 | 590,832,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$145,928,000
Investing CF
$-66,887,000
Financing CF
$11,472,000
CapEx
$-66,887,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$3.89
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-255,953,000
Inventory
$54,137,000
Receivables
$104,138,000
ST Investments
—
EBIT TTM
$93,794,000
Pretax Income TTM
$72,554,000
Interest Exp TTM
$21,240,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$668,467,968
EBITDA
$115,629,000
Free Cash Flow
$44,496,752
Enterprise Value
$3,244,648,448
Total Cash
$472,675,008
Total Debt
$867,720,000
Shares Out
34,675,145
Trailing EPS
$3.86
Book Value
$14.96
ROE
36.3%
ROA
4.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 605,494,000 | 108,583,000 | 190,291,000 | 1,068,373,000 | 595,273,000 | 473,100,000 | 192,840,000 |
| Dec 2024 | 441,540,000 | 37,496,000 | 35,464,000 | 804,076,000 | 575,473,000 | 228,603,000 | 48,803,000 |
| Dec 2023 | 241,623,000 | -28,727,000 | -25,028,000 | 706,047,000 | 568,845,000 | 137,202,000 | -13,028,000 |
| Dec 2022 | 93,459,000 | -31,437,000 | -36,231,000 | 277,147,000 | 89,772,000 | 187,375,000 | -45,817,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$2.31
Max Pain — expiry 2026-10-02
max pain strike: $85.00 · spot: $84.18 · call oi: 3,794 · put oi: 8,937
Expected Move to 2026-10-02:
±$4.55
(5.40%) —
implied range
$79.63 –
$88.73
· ATM straddle on $84.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATRC | AtriCure, Inc. | $2.97B | $58.38 | — |
| IRTC | iRhythm Holdings, Inc. | $3.64B | $110.38 | — |
| PLSE | PULSE BIOSCIENCES, INC. | $3.68B | $51.63 | — |
| AXGN | Axogen, Inc. | $2.33B | $43.39 | — |
| BFLY | Butterfly Network, Inc. | $2.30B | $9.39 | — |
News headlines (Yahoo Finance, 1h cache)
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
2026-09-03 18:00 · Yahoo
TransMedics to Present at Upcoming September Investor Conferences
2026-08-31 20:05 · Yahoo
TransMedics Targets $2B Opportunity With Kidney Push, European Expansion
2026-08-18 05:01 · Yahoo
TransMedics (TMDX) Q2 2026 Earnings Call Transcript
2026-08-11 23:43 · Yahoo
TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract
2026-08-05 17:42 · Yahoo
TransMedics Group (TMDX) Stock Looks Cheap On Earnings But Full After 171% Gain
2026-08-05 06:09 · Yahoo
TransMedics Group Inc (TMDX) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ...
2026-08-05 05:07 · Yahoo
TransMedics Group Q2 Earnings Call Highlights
2026-08-05 03:03 · Yahoo
TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say
2026-08-04 23:30 · Yahoo
Is UBS Coverage and New Equity Awards Reframing TransMedics’ (TMDX) Transplant Platform Narrative?
2026-08-04 16:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.